Twist in a Long-Standing Glaucoma Treatment Journey: Delayed Hypersensitivity to Benzalkonium Chloride

Abstract A 79-year-old male with a long-standing history of pseudoexfoliative glaucoma presented with persistent periocular eczema, itching and eyelid swelling. Despite multiple consultations and empirical treatments for presumed allergic conjunctivitis and dermatological conditions, his symptoms persisted. The intraocular pressure remained well controlled, and there were no signs of intraocular inflammation or glaucomatous progression. After ruling out common allergens and other causes, a trial switch from a benzalkonium chloride (BAK)-preserved anti-glaucoma medication to a preservative-free formulation resulted in complete symptom resolution. This case emphasizes the importance of considering preservative toxicity, even after years of well-tolerated use, and the need for a high index of suspicion for delayed hypersensitivity reactions.

Institutions

Publication Details

Journal
TNOA Journal of Ophthalmic Science and Research
Published
2025-10-01
DOI
https://doi.org/10.4103/tjosr.tjosr_48_25
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Twist in a Long-Standing Glaucoma Treatment Journey: Delayed Hypersensitivity to Benzalkonium Chloride

TNOA Journal of Ophthalmic Science and Research
Glaucoma and retinal disorders
article

Twist in a Long-Standing Glaucoma Treatment Journey: Delayed Hypersensitivity to Benzalkonium Chloride

article en

Abstract

Abstract A 79-year-old male with a long-standing history of pseudoexfoliative glaucoma presented with persistent periocular eczema, itching and eyelid swelling. Despite multiple consultations and empirical treatments for presumed allergic conjunctivitis and dermatological conditions, his symptoms persisted. The intraocular pressure remained well controlled, and there were no signs of intraocular inflammation or glaucomatous progression. After ruling out common allergens and other causes, a trial switch from a benzalkonium chloride (BAK)-preserved anti-glaucoma medication to a preservative-free formulation resulted in complete symptom resolution. This case emphasizes the importance of considering preservative toxicity, even after years of well-tolerated use, and the need for a high index of suspicion for delayed hypersensitivity reactions.

TNOA Journal of Ophthalmic Science and ResearchVol. 63(4)
Aravind Eye Hospital (IN)
Good health and well-being
Openalex Percentile: Top 33%
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.